Physician profile
Vipul P Patel
NPI 1255516761
$16,721.18
in general payments reported to CMS, 2019-2025
25 companies · $7,017 in 2025
The $7,017 reported for 2025 was more than what 85% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $252 · 2020: $2,705 · 2021: $1,012 · 2022: $1,652 · 2023: $3,646 · 2024: $437 · 2025: $7,017.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $5,921 · Food and Beverage: $2,704 · Honoraria: $1,500 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $975.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $5,921.17 |
| Food and Beverage | $2,703.73 |
| Honoraria | $1,500.00 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $975.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Renerve LTD | $6,055.70 | 2025 | Nervalign Nerve Cuff |
| Microaire Surgical Instruments LLC | $4,075.00 | 2020-2023 | Smart Release |
| Integra Lifesciences Corporation | $2,285.18 | 2020-2023 | Tenoglide |
| Skeletal Dynamics INC | $857.51 | 2023-2025 | Align, Implate, Ijs |
| Arthrex, INC. | $542.10 | 2020 | |
| Cepheid | $394.00 | 2020 | |
| Axogen | $371.70 | 2019-2024 | Avance Nerve Graft, Axoguard Ha+ Nerve Protector, Axoguard Nerve Cap |
| Endo Pharmaceuticals INC. | $244.99 | 2019-2024 | Xiaflex |
| Trimed, INC. | $224.24 | 2021-2022 | |
| Medartis INC. | $223.11 | 2021 | |
| Highridge Medical LLC | $182.68 | 2024-2025 | Biomet Spinalpak Non-Invasive Spine Fusion Stimulator System |
| Acumed LLC | $171.91 | 2023 | Innate Implant |
| Endo USA, INC. | $171.67 | 2024-2025 | Xiaflex |
| Smith+Nephew, INC. | $167.66 | 2019-2023 | Multifix |
| Ossio INC | $158.65 | 2023 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotronik INC. | $142.41 | 2025 | Acticor 7 Vr-T Dx |
| Depuy Synthes Sales INC. | $85.57 | 2023 | Na |
| Zimvie INC. | $81.95 | 2023-2024 | |
| Zimmer Biomet Holdings, INC. | $73.60 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $49.70 | 2024-2025 | |
| Kerecis Limited | $46.09 | 2021-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Ebi, LLC | $42.54 | 2025 | Biomet Spinalpak Non-Invasive Spine Fusion Stimulator System |
| Orthofix Medical, INC. | $38.45 | 2019-2020 | |
| Alnylam Pharmaceuticals INC. | $19.83 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.94 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vipul Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.